This is a non-capital-intensive revenue-sharing agreement with no disclosed financial projections. Monitor future filings for initial sales data and commercialization updates to assess revenue contribution. The partnership is terminable on 30 days' notice, limiting downside risk but also signaling low commitment.
Price Chart
Executive Summary
MMA.INC announced an exclusive strategic marketing partnership with Precision Peptide Company Inc. (CSE: BPC) to market peptide recovery products across its global combat sports ecosystem. Under the agreement, MMA will receive 50% of net revenue from MMA-sourced sales in year one and 25% thereafter, with no capital investment required. The partnership provides a new revenue vertical but no financial projections or current revenue figures were disclosed.
Key Facts
- Exclusive partnership with Precision Peptide Company Inc. (CSE: BPC) for peptide recovery products
- MMA receives 50% of net revenue from MMA-sourced sales in year 1, then 25% for remainder of term
- No capital investment required from MMA
- Products are U.S. manufactured and third-party tested
- MMA ecosystem includes ~530,000 user profiles, 75,000+ active students, 800+ verified gyms globally
- Partnership may be terminated by either party upon 30 days' written notice
- 12-month tail period for revenue share after termination/expiration
Financial Impact
No revenue or financial projections provided; revenue share structure is 50/25% of net revenue from MMA-sourced sales, but no baseline or forecast given
Risk Factors
- No financial projections or revenue guidance provided; actual revenue contribution uncertain
- Partnership terminable on 30 days' notice, indicating potential instability
- Peptide market regulatory risks and compliance requirements
- MMA's small market cap ($14M) makes even modest revenue streams potentially material
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-022412 |
| Document: form6-k.htm | 0001493152-26-022412 |
| Document: 0001493152-26-022412-index-headers.html | 0001493152-26-022412 |
| Document: 0001493152-26-022412-index.html | 0001493152-26-022412 |
| Document: 0001493152-26-022412.txt | 0001493152-26-022412 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $0.2912 | awaiting T+60 | — | $0.3396 (+16.62%) |
Sep 29, 2026 28d ago | 6-K | $0.3900 | awaiting T+60 | — | $0.3396 (−12.92%) |
Sep 22, 2026 5w ago | 6-K | $0.4380 | awaiting T+60 | — | $0.3396 (−22.47%) |
Sep 17, 2026 5w ago | 6-K | $0.4343 | awaiting T+60 | — | $0.3396 (−21.81%) |
Sep 15, 2026 6w ago | 6-K | $0.3949 | awaiting T+60 | — | $0.3396 (−14.00%) |
Sep 10, 2026 6w ago | 6-K | $0.4035 | awaiting T+60 | — | $0.3396 (−15.84%) |
Sep 1, 2026 8w ago | 6-K | $0.4223 | awaiting T+60 | — | $0.3396 (−19.58%) |
Aug 20, 2026 9w ago | 6-K | $0.5662 | awaiting T+60 | — | $0.3396 (−40.02%) |
Jul 15, 2026 14w ago | 6-K | $0.4850 $0.3442 | ▼ −29.03% | ▼ −31.56% | $0.3396 (−29.98%) |
Jul 1, 2026 16w ago | 6-K | $0.5400 $0.4166 | ▼ −22.85% | ▼ −25.81% | $0.3396 (−37.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers